Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_assertion wasGeneratedBy ECO_0000203 NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_assertion wasDerivedFrom befree-20150227 NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_assertion SIO_000772 7911242 NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_assertion evidence source_evidence_literature NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.
- NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_assertion description "[Because of its restricted normal tissue distribution and abundant expression in the stroma of over 90% of breast, colorectal, and lung carcinomas, FAP alpha is under clinical evaluation as a target for immunodetection and immunotherapy of epithelial cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310089.RAmLhvjdg_gOlpYllxiAiENMd_Oiq8C-y6SZxe7zgtWB0130_provenance.